A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

NCT03825783 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Patients were enrolled under global Phase 1/2 protocol RP-L201-0318.

Conditions

Leukocyte Adhesion Defect - Type I

Interventions

BIOLOGICAL: RP-L201

Sponsor

Rocket Pharmaceuticals Inc.